"FDA" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonBlood pressure tech floods the market after FDA relaxes wearables oversight - statnews.com
Blood pressure tech floods the market after FDA relaxes wearables oversight statnews.com
US FDA decision date extended for SERENA-6 filing of camizestrant to enable review of additional ...
US FDA decision date extended for SERENA-6 filing of camizestrant to enable review of additional data AstraZeneca
FDA panel recommends updating Covid shots to target XFG strain - NBC News
Viridian, awaiting FDA decision, taps WuXi Bio in supply deal - Fierce Pharma
Viridian, awaiting FDA decision, taps WuXi Bio in supply deal Fierce Pharma
Seasoning sold at SC Walmart stores recalled due to salmonella risk, FDA says - Post and Courier
Seasoning sold at SC Walmart stores recalled due to salmonella risk, FDA says Post and Courier
FDA extends Beren’s rare disease review after info request, further stretching saga - Fierce Biotech
FDA extends Beren’s rare disease review after info request, further stretching saga Fierce Biotech
Warnings issued to Alabama doctors against non-FDA-approved peptides amid social media popularity...
Warnings issued to Alabama doctors against non-FDA-approved peptides amid social media popularity WSFA
ADC from AbbVie's ImmunoGen takeout wins FDA approval for rare blood cancer - FirstWord Pharma
ADC from AbbVie's ImmunoGen takeout wins FDA approval for rare blood cancer FirstWord Pharma
With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset - Fierce Pharma
With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset Fierce Pharma
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer - BioSpace
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer BioSpace
FDA Approves OTC Switch for Topical Acne Treatment - Medscape
MNKD Stock Eyes Best Month Since 2022 Ahead Of FDA Decision On Pediatric Diabetes Treatment - Yah...
MNKD Stock Eyes Best Month Since 2022 Ahead Of FDA Decision On Pediatric Diabetes Treatment Yahoo Finance
FDA Grants Fast Track Designation to STX-0712 for R/R CMML - Targeted Oncology
FDA Grants Fast Track Designation to STX-0712 for R/R CMML Targeted Oncology
Industry Confidence In FDA May Hinge On CBER, CDER Leadership, Inside Health Policy - Morgan Lewis
Industry Confidence In FDA May Hinge On CBER, CDER Leadership, Inside Health Policy Morgan Lewis
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC - OncLive
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC OncLive
Durvalumab Plus BCG Earns FDA Approval For High-Risk NMIBC - CancerNetwork
Durvalumab Plus BCG Earns FDA Approval For High-Risk NMIBC CancerNetwork
FDA Approves Durvalumab and BCG for High-Risk NMIBC - Oncology Nursing News
FDA Approves Durvalumab and BCG for High-Risk NMIBC Oncology Nursing News
FDA provides additional examples, clarity in human factors guidance - RAPS.org
FDA provides additional examples, clarity in human factors guidance RAPS.org
FDA Approves Imfinzi Plus BCG for High-Risk Bladder Cancer - Cure Today
FDA Approves Imfinzi Plus BCG for High-Risk Bladder Cancer Cure Today
US FDA approves AbbVie's rare blood cancer drug - Reuters
FDA Releases Discussion Paper Ahead of Traceability Public Meeting in June - Quality Assurance & ...
FDA Releases Discussion Paper Ahead of Traceability Public Meeting in June Quality Assurance & Food Safety
FDA Grants Priority Review to Finerenone sNDA for Type 1 Diabetes-Associated CKD - Docwire News
FDA Grants Priority Review to Finerenone sNDA for Type 1 Diabetes-Associated CKD Docwire News
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC - Targeted Oncology
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC Targeted Oncology
FDA Approves Pivekimab Sunirine for Blastic Plasmacytoid Dendritic Cell Neoplasm - OncLive
FDA Approves Pivekimab Sunirine for Blastic Plasmacytoid Dendritic Cell Neoplasm OncLive
Neladalkib Earns FDA Priority Review in ALK-Positive NSCLC - CancerNetwork
Neladalkib Earns FDA Priority Review in ALK-Positive NSCLC CancerNetwork
FDA Updates Pesticide Monitoring Compliance Program - Quality Assurance & Food Safety
FDA Updates Pesticide Monitoring Compliance Program Quality Assurance & Food Safety
FDA Grants Priority Review for Bezuclastinib Plus Sunitinib in GIST - Targeted Oncology
FDA Grants Priority Review for Bezuclastinib Plus Sunitinib in GIST Targeted Oncology
FDA Approves Pivekimab Sunirine for BPDCN - Targeted Oncology
FDA Approves Pivekimab Sunirine for BPDCN Targeted Oncology
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant - Ph...
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant Pharmaceutical Executive
FDA Grants Priority Review to Saroglitazar NDA for Primary Biliary Cholangitis - HCPLive
FDA Grants Priority Review to Saroglitazar NDA for Primary Biliary Cholangitis HCPLive
FDA Approves Pivekimab Sunirine for BPDCN - Oncology News Central
FDA Approves Pivekimab Sunirine for BPDCN Oncology News Central
US FDA advisers vote in favor of recommending COVID vaccines target XFG variant - Reuters
US FDA advisers vote in favor of recommending COVID vaccines target XFG variant Reuters
Recon: FDA delays on AstraZeneca’s experimental breast cancer therapy; Abbott earns CE mark for d...
Balance Ophthalmics receives FDA 510(k) clearance for wireless-enabled nocturnal IOP device - Oph...
Balance Ophthalmics receives FDA 510(k) clearance for wireless-enabled nocturnal IOP device Ophthalmology Times
FDA decision on BBP-418 for LGMD2i expected in late November - Muscular Dystrophy News
FDA decision on BBP-418 for LGMD2i expected in late November Muscular Dystrophy News
FDA Approves Durvalumab Plus BCG for High-Risk Non–Muscle-Invasive Bladder Cancer - Pharmacy Times
FDA Approves Durvalumab Plus BCG for High-Risk Non–Muscle-Invasive Bladder Cancer Pharmacy Times
Pharmacy NDC Transition FDA 12 Digit Rule Overview - Specialty Pharmacy Continuum
Pharmacy NDC Transition FDA 12 Digit Rule Overview Specialty Pharmacy Continuum
FDA extends adrabetadex NDA review for infantile-onset Niemann-Pick disease type C - Contemporary...
FDA extends adrabetadex NDA review for infantile-onset Niemann-Pick disease type C Contemporary Pediatrics
FDA Modernizes Oversight of Pesticides in Food - Food Safety Magazine
FDA Modernizes Oversight of Pesticides in Food Food Safety Magazine
A Drama-Free FDA Is a Win for the White House - Bloomberg.com
A Drama-Free FDA Is a Win for the White House Bloomberg.com
FDA accelerated approval of Hepcludex significant milestone for US HDV market - Clinical Trials A...
FDA accelerated approval of Hepcludex significant milestone for US HDV market Clinical Trials Arena
Clariant secures FDA approval for bio-based Licocare™ RBW additives in rigid PVC food-contact app...
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board o...
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors PR Newswire
FDA Expands Approval of Linzess for Patients as Young as 2 Years - Drug Topics
FDA Expands Approval of Linzess for Patients as Young as 2 Years Drug Topics
FDA Investigates New Salmonella Outbreak Linked to MOGO Moringa Capsules - Quality Assurance & Fo...
FDA Investigates New Salmonella Outbreak Linked to MOGO Moringa Capsules Quality Assurance & Food Safety
Sunscreen: How to Help Protect Your Skin from the Sun - fda.gov
Sunscreen: How to Help Protect Your Skin from the Sun fda.gov
FDA delays ruling on AstraZeneca drug after negative adcomm vote - Fierce Biotech
FDA delays ruling on AstraZeneca drug after negative adcomm vote Fierce Biotech
Beren Therapeutics Announces FDA Extension of Review Period for New Drug Application (NDA) for Ad...
FDA OKs Immunotherapy-BCG Combo for High-Risk Bladder Cancer - MedPage Today
FDA OKs Immunotherapy-BCG Combo for High-Risk Bladder Cancer MedPage Today
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer - MedCity ...
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer MedCity News
FDA Approves Novel Targeted Therapy for Rare Blood Cancer - Medscape
FDA Approves Novel Targeted Therapy for Rare Blood Cancer Medscape
Alife Health Receives FDA Clearance for AI-Powered Embryo Assessment - PR Newswire
Alife Health Receives FDA Clearance for AI-Powered Embryo Assessment PR Newswire
CIDRAP Op-Ed: Manufacturing a scandal: What the FDA’s COVID vaccine pediatric death review actual...
FDA grants breakthrough designation to Coredio heart failure assessment platform - Medical Economics
FDA grants breakthrough designation to Coredio heart failure assessment platform Medical Economics
Clariant Wins FDA Approval for Bio-Based PVC Additives - PlasticsToday
Clariant Wins FDA Approval for Bio-Based PVC Additives PlasticsToday
Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet -...
Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet BioSpace
FDA Approves DECNUPAZ for Blastic Plasmacytoid Dendritic Cell Neoplasm - The Clinical Trial Vanguard
FDA Approves DECNUPAZ for Blastic Plasmacytoid Dendritic Cell Neoplasm The Clinical Trial Vanguard
Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment - MassDevice
Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment MassDevice
Tracking Food Industry Pledges to Remove Petroleum Based Food Dyes - fda.gov
Tracking Food Industry Pledges to Remove Petroleum Based Food Dyes fda.gov
IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use - Yahoo Finance
IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use Yahoo Finance
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the...
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon The Cancer Letter
FDA Approves Pivekimab Sunirine in Rare Hematologic Malignancy - CancerNetwork
FDA Approves Pivekimab Sunirine in Rare Hematologic Malignancy CancerNetwork
ReST Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for...
Big Tobacco comes out on top after US FDA shake-up - Reuters
FDA Announces Recall on Popular Candy Due To Life-Threatening Allergen - Allrecipes
FDA Announces Recall on Popular Candy Due To Life-Threatening Allergen Allrecipes
The Evolving Biopharma Regulatory Landscape: Q&A with Harpreet Singh, MD - Pharmaceutical Executive
The Evolving Biopharma Regulatory Landscape: Q&A with Harpreet Singh, MD Pharmaceutical Executive
PINK: Q1 2026 saw recurring revenue growth, FDA approval for Claire OCT + AI, and improved net lo...
PINK: Q1 2026 saw recurring revenue growth, FDA approval for Claire OCT + AI, and improved net loss TradingView
Improving FDA & Biopharma's Relationship - Pharmaceutical Executive
Improving FDA & Biopharma's Relationship Pharmaceutical Executive
FDA Extends Action Date for Camizestrant in Advanced Breast Cancer - Targeted Oncology
FDA Extends Action Date for Camizestrant in Advanced Breast Cancer Targeted Oncology
Infant Formula Homepage - fda.gov
Infant Formula Homepage fda.gov
FDA Grants Priority Review to Neladalkib NDA for ALK-Positive NSCLC - Targeted Oncology
FDA Grants Priority Review to Neladalkib NDA for ALK-Positive NSCLC Targeted Oncology
Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear P...
Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangit...
FDA Recall on Gas X: What to Know About Recalled Batches and Safety - EatingWell
FDA Recall on Gas X: What to Know About Recalled Batches and Safety EatingWell
Accelerating Rare disease Cures (ARC) Program - fda.gov
AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi - Fierce Pharma
AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi Fierce Pharma
FDA Extends Decision Date for Camizestrant in HR+ Advanced Breast Cancer With an Emergent ESR1 Mu...
Fifty Years of the Medical Device Amendments - fda.gov
FDA Approved Pivekimab Sunirine‑Pvzy for Adult Patients – BPDCN International Registry - Oncodaily
FDA Approved Pivekimab Sunirine‑Pvzy for Adult Patients – BPDCN International Registry Oncodaily
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race - Psych...
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race Psychedelic Alpha
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication - Yahoo Finance
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication Yahoo Finance
FDA advisers to weigh composition of COVID vaccines for 2026-2027 - whbl.com
FDA advisers to weigh composition of COVID vaccines for 2026-2027 whbl.com
FDA delays decision on AstraZeneca breast cancer pill - BioPharma Dive
FDA delays decision on AstraZeneca breast cancer pill BioPharma Dive
Alabama warns healthcare providers against use of non-FDA-approved peptides - Reuters
Alabama warns healthcare providers against use of non-FDA-approved peptides Reuters
FDA Approves Pivekimab Sunirine-pvzy for BPDCN - Oncology Nursing News
FDA Approves Pivekimab Sunirine-pvzy for BPDCN Oncology Nursing News
FDA Grants Coredio Breakthrough Designation for AI Platform Bringing Advanced Heart Failure Asses...
FDA Grants Coredio Breakthrough Designation for AI Platform Bringing Advanced Heart Failure Assessment Beyond the Hospital Business Wire
Sanofi’s venglustat accepted for priority review by FDA - The Pharma Letter
Sanofi’s venglustat accepted for priority review by FDA The Pharma Letter
FDA Expands Market Access, Authorizes New ENDS Products - fda.gov
FDA Expands Market Access, Authorizes New ENDS Products fda.gov
FDA refuses to be ghosted on clinical trial data - JD Supra
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreat...
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer Investing News Network
OTLK Stock Rocket Nearly 140%: FDA's Lytenava Approval Pushes Stock On Track For Best Week On Rec...
OTLK Stock Rocket Nearly 140%: FDA's Lytenava Approval Pushes Stock On Track For Best Week On Record Stocktwits
Ex-FDA official joins ALS trial push after first-ever SPA for ALS - Stock Titan
Ex-FDA official joins ALS trial push after first-ever SPA for ALS Stock Titan
FDA oncology roundup: AbbVie’s rare cancer approval, AstraZeneca in breast cancer limbo - Yahoo
FDA oncology roundup: AbbVie’s rare cancer approval, AstraZeneca in breast cancer limbo Yahoo
Raffaele Colombo: FDA Approves Pivekimab Sunirine Based on CADENZA Trial - Oncodaily
Raffaele Colombo: FDA Approves Pivekimab Sunirine Based on CADENZA Trial Oncodaily
FDA OKs Decnupaz for Adults With Blastic Plasmacytoid Dendritic Cell Neoplasm - Cure Today
FDA OKs Decnupaz for Adults With Blastic Plasmacytoid Dendritic Cell Neoplasm Cure Today
FDA Approves Durvalumab In Combination With Bacillus Calmette-Guerin - TradingView
FDA Approves Durvalumab In Combination With Bacillus Calmette-Guerin TradingView
APYX: FDA-cleared technologies and cost discipline drive growth in the expanding surgical aesthet...
APYX: FDA-cleared technologies and cost discipline drive growth in the expanding surgical aesthetics market TradingView
Clariant obtains FDA approval for renewable rice bran wax additives in PVC food packs - Packaging...
Clariant obtains FDA approval for renewable rice bran wax additives in PVC food packs Packaging Insights
FDA Announces Recall on Supplement Due to Multistate Salmonella Outbreak—Here’s What to Know - Ea...
FDA Announces Recall on Supplement Due to Multistate Salmonella Outbreak—Here’s What to Know EatingWell
FDA clears AbbVie’s Decnupaz for rare blood cancer - The Pharma Letter
FDA clears AbbVie’s Decnupaz for rare blood cancer The Pharma Letter
Cogent Biosciences Announces FDA Acceptance of New Drug Application with Priority Review for Bezu...
Cogent Biosciences Announces FDA Acceptance of New Drug Application with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST Investing News Network
No child deaths definitively linked to Covid shots, FDA says - NBC News
No child deaths definitively linked to Covid shots, FDA says NBC News